Efficacy of HE4, CA125, Risk of Malignancy Index and Risk of Ovarian Malignancy Index to Detect Ovarian Cancer in Women with Presumed Benign Ovarian Tumours: A Prospective, Multicentre Trial

Efficacy of HE4, CA125, Risk of Malignancy Index and Risk of Ovarian Malignancy Index to Detect Ovarian Cancer in Women with Presumed Benign Ovarian Tumours: A Prospective, Multicentre Trial

Background: Presumed benign ovarian tumours (PBOT) are defined by the International Ovarian Tumour Analysis (IOTA) group, without suspected sonographic criteria of cancer, without ascites or metastasis. The aim is to evaluate the efficacy of human epididymis protein 4 (HE4), cancer antigen 125 (CA12...

Full description

Bibliographic Details
Main Authors: Vincent Dochez, Mélanie Randet, Céline Renaudeau, Jérôme Dimet, Aurélie Le Thuaut, Norbert Winer, Thibault Thubert, Edouard Vaucel, Hélène Caillon, Guillaume Ducarme
Format: Article
Language:English
Published: MDPI AG 2019-10-01
Series:Journal of Clinical Medicine
Subjects:
he4
ca125
ovarian cancer
presumed benign ovarian tumour
rmi
roma
Online Access:https://www.mdpi.com/2077-0383/8/11/1784

Internet

https://www.mdpi.com/2077-0383/8/11/1784

Similar Items